Fátima Cardoso
- Oncology top 0.05%
- Cancer Research top 0.02%
- Molecular Biology top 0.5%
- Pulmonary and Respiratory Medicine top 0.2%
- Genetics top 0.2%
- Co-authors
- Elżbieta SenkusMartine PiccartFrédérique Penault‐LlorcaPhilip PoortmansS. KyriakidesNadia HarbeckChristos SotiriouSophia Zackrisson
- Topics
- Breast Cancer Treatment Studies (177 papers)HER2/EGFR in Cancer Research (122 papers)Cancer Treatment and Pharmacology (95 papers)
- Partner nations
- PortugalBelgiumUnited States
In The Last Decade
Fátima Cardoso
378 papers receiving 24.8k citations
Hit Papers
Peers
Comparison fields: 5 of 181
- Oncology 13.8k
- Cancer Research 10.5k
- Molecular Biology 7.4k
- Pulmonary and Respiratory Medicine 4.9k
- Genetics 3.2k
Countries citing papers authored by Fátima Cardoso
This map shows the geographic impact of Fátima Cardoso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fátima Cardoso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fátima Cardoso more than expected).
Fields of papers citing papers by Fátima Cardoso
This network shows the impact of papers produced by Fátima Cardoso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fátima Cardoso. The network helps show where Fátima Cardoso may publish in the future.
Co-authorship network of co-authors of Fátima Cardoso
This figure shows the co-authorship network connecting the top 25 collaborators of Fátima Cardoso. A scholar is included among the top collaborators of Fátima Cardoso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fátima Cardoso. Fátima Cardoso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522breakdown → | 47 |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 10 | |
| 7 | 1 | |
| 8 | 7 | |
| 9 | 20 | |
| 10 | 67 | |
| 11 | 4 | |
| 12 | 2 | |
| 13 | 11 | |
| 14 | 5 | |
| 15 | 4 | |
| 16 | 10 | |
| 17 | 55 | |
| 18 | 11 | |
| 19 | [News in the medical treatment of breast cancer]. | 4 |
| 20 | HER-2/neu evaluation by immunohistochemistry and fluorescence in situ hybridization in breast cancer: implications for daily laboratory practice. | 11 |
About Fátima Cardoso
Fátima Cardoso is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 403 papers that have together received 25.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (177 papers), HER2/EGFR in Cancer Research (122 papers) and Cancer Treatment and Pharmacology (95 papers). The work is most often cited by research in Cancer Research (10.5k citations), Oncology (13.8k citations) and Pulmonary and Respiratory Medicine (4.9k citations). Fátima Cardoso has collaborated with scholars based in Portugal, Belgium and United States. Frequent co-authors include Elżbieta Senkus, Martine Piccart, Frédérique Penault‐Llorca, Philip Poortmans, S. Kyriakides, Nadia Harbeck, Christos Sotiriou, Sophia Zackrisson, Emiel J. Rutgers and Shinji Ohno. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.